Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
126.03
-1.64 (-1.28%)
Nov 13, 2024, 4:00 PM EST - Market closed
Ascendis Pharma Analyst Ratings
Total Analysts
13
Consensus Rating
Strong Buy
Price Target
$195.92
Upside
+55.46%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $170 | Buy | Reiterates | $170 | +34.89% | Nov 4, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $180 → $174 | Buy | Maintains | $180 → $174 | +38.06% | Oct 23, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $157 → $160 | Strong Buy | Maintains | $157 → $160 | +26.95% | Oct 21, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $175 → $191 | Strong Buy | Maintains | $175 → $191 | +51.55% | Sep 23, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $264 → $289 | Buy | Maintains | $264 → $289 | +129.31% | Sep 17, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $178 → $207 | Strong Buy | Maintains | $178 → $207 | +64.25% | Sep 17, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $191 → $205 | Buy | Maintains | $191 → $205 | +62.66% | Sep 17, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $180 → $190 | Buy | Reiterates | $180 → $190 | +50.76% | Sep 17, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $180 → $200 | Strong Buy | Maintains | $180 → $200 | +58.69% | Sep 17, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $170 | Buy | Reiterates | $170 | +34.89% | Sep 16, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $170 | Buy | Reiterates | $170 | +34.89% | Sep 9, 2024 |
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $180 | Hold → Buy | Upgrades | $180 | +42.82% | Sep 5, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $193 → $178 | Strong Buy | Maintains | $193 → $178 | +41.24% | Sep 4, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $174 → $165 | Buy | Maintains | $174 → $165 | +30.92% | Sep 4, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $175 → $157 | Strong Buy | Maintains | $175 → $157 | +24.57% | Sep 4, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $165 → $175 | Strong Buy | Maintains | $165 → $175 | +38.86% | Sep 4, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.